Cargando…
Research Progress on (18)F-Labeled Agents for Imaging of Myocardial Perfusion with Positron Emission Tomography
Coronary artery disease (CAD) is the leading cause of death in the world. Myocardial perfusion imaging (MPI) plays a significant role in non-invasive diagnosis and prognosis of CAD. However, neither single-photon emission computed tomography nor positron emission tomography clinical MPI agents can a...
Autores principales: | Mou, Tiantian, Zhang, Xianzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154634/ https://www.ncbi.nlm.nih.gov/pubmed/28358340 http://dx.doi.org/10.3390/molecules22040562 |
Ejemplares similares
-
An (18)F-Labeled Poly(ADP-ribose)
Polymerase Positron Emission Tomography Imaging Agent
por: Zmuda, Filip, et al.
Publicado: (2018) -
Synthesis and Evaluation of (18)F-labeled Pyridaben Analogues for Myocardial Perfusion Imaging in Mice, Rats and Chinese mini-swine
por: Mou, Tiantian, et al.
Publicado: (2016) -
Rest/stress myocardial perfusion imaging by positron emission tomography with (18)F-Flurpiridaz: A feasibility study in mice
por: Bengs, Susan, et al.
Publicado: (2022) -
Al(18)F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging
por: Cleeren, Frederik, et al.
Publicado: (2017) -
Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022)